Tikcro Technologies (TIKRF) 0.3500 $TIKRF /C O R R E C T

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Tikcro Technologies (TIKRF) 0.3500 $TIKRF

/C O R R E C T I O N -- Tikcro Technologies Ltd./
PR Newswire - Tue Aug 09, 8:41AM CDT
In the news release, Tikcro Technologies Reports Second Quarter 2016 Results, issued Aug. 9, 2016 by Tikcro Technologies Ltd. over PR Newswire, we are advised by a representative for the company that in the table "Statements of Operations," total operating expenses for the three months ended June 30, 2015 should be $262. The complete, corrected release follows:

Tikcro Technologies Reports Second Quarter 2016 Results
PR Newswire - Tue Aug 09, 7:00AM CDT
Tikcro Technologies Ltd. (OTCQB: TIKRF) today reported results for the second quarter ended June 30, 2016.

Tikcro Technologies Reports First Quarter 2016 Results
PR Newswire - Wed Jun 01, 12:43PM CDT
Tikcro Technologies Ltd. (OTCQX: TIKRF) today reported financial results for the first quarter ended March 31, 2016.

OTC Markets Group Welcomes Tikcro Technologies to OTCQX
PR Newswire - Tue Dec 29, 6:00AM CST
OTC Markets Group Inc. (OTCQX: OTCM), operator of Open, Transparent and Connected financial markets, today announced Tikcro Technologies Ltd. (OTCQX: TIKRF), an Israel-based developer of second generation antibodies binding to cancer-immune modulators, currently in pre-clinical stage, has qualified to trade on the OTCQX® Best Market.

Tikcro Adds New Cancer Immune Modulators Targets
PR Newswire - Tue Dec 15, 3:05PM CST
Tikcro Technologies Ltd. (OTCQB: TIKRF) today announced that it has extended an ongoing research and license agreement with Yeda Research and Development Company Ltd., the technology transfer arm of the Weizmann Institute of Science in Israel, for additional targets for cancer immune modulators generated from a certain lab at the Weizmann Institute of Science.

Tikcro Technologies Announces 2015 Annual General Meeting
PR Newswire - Tue Nov 24, 7:30AM CST
Tikcro Technologies Ltd. (OTCQB: TIKRF) today announced that its Annual General Meeting of Shareholders will be held on December 29, 2015 at 11:00 a.m. Israel time, at the law offices of Goldfarb Seligman & Co., Electra Tower, 98 Yigal Allon Street, 36th Floor, Tel Aviv, Israel.

Tikcro Technologies Launches New Website
PR Newswire - Mon Oct 26, 10:37AM CDT
Tikcro Technologies Ltd. (OTCQB: TIKRF) today announced the launch of a new corporate website. The website features information on the Company's approach of using a novel 3D antigen design methodology to generate antibodies for the treatment of certain cancer indications by addressing immune modulators. Specifically, it describes the Company's product pipeline of antibodies for the blocking of CTLA4 and PD1 interactions with its respective ligands. The website also has a comprehensive investor section with up to date financial information and a corporate presentation. The new website is located at www.tikcro.com.

Tikcro to Proceed with CTLA4 and PD1 Antibody Generation Plan
PR Newswire - Mon Jun 15, 7:30AM CDT
Tikcro Technologies Ltd. (OTCQB: TIKRF) today announced that it will proceed with a pre-clinical plan for the generation and verification of new antibodies targeting the modulation of CTLA4 and PD1 cancer checkpoints.

Tikcro Technologies Announces Approval to Continue Trading on OTCQB
PR Newswire - Tue May 05, 8:42AM CDT
Tikcro Technologies Ltd. (OTCQB: TIKRF) today announced that the Company was approved to continue trading on OTCQB Marketplace, the market for developmental stage companies.

Tikcro Technologies Announces Shareholders' Meeting
PR Newswire - Wed Feb 18, 8:00AM CST
Tikcro Technologies Ltd. (OTC PK: TIKRF) today announced that an Extraordinary General Meeting of Shareholders will be held on March 25, 2015 at 12:00 p.m. Israel time, at the law offices of Goldfarb Seligman & Co., Electra Tower, 98 Yigal Allon Street, 36th Floor, Tel Aviv, Israel.

Tikcro Signs Research and License Agreement Regarding Cancer Immune Checkpoint Antibodies
PR Newswire - Tue Dec 30, 8:00AM CST
Tikcro Technologies Ltd. (OTC PK: TIKRF) today announced that it has entered into a research and license agreement with Yeda Research and Development Company Ltd., the technology transfer arm of the Weizmann Institute of Science in Israel. This agreement is for the development of new antibodies originating from specified research at the Weizmann Institute of Science addressing identified targets of cancer immune checkpoints.

Tikcro Technologies Reports Third Quarter 2014 Results
PR Newswire - Thu Nov 13, 8:00AM CST
Tikcro Technologies Ltd. (OTC PK: TIKRF) today reported results for the third quarter ended September 30, 2014.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Replay Sports Cards Expands to Greenville With New Franchise

Updated Category News Views 0

An Old Hobby Gets New Life in Greenville Isn't it something when a hobby from your childhood eventually morphs into a business venture? That's exactly what's happening in Greenville, North Carolina, where Replay Sports Cards is laying down roots. Thanks to Jim and Jake Whitehurst's fresh franchise agreement, the card community along the eastern seaboard is about to have a...

Continue Reading
Texas Institute Leads Trailblazing Arrhythmia Study

Updated Category News Views 2

Breaking New Ground in Heart Rhythm Treatment Well, here's a twist that even the stock market folks might envy—pioneering innovation in healthcare. This time, it’s not about tech stocks or a bull market, but about real human lives. The Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center in Austin has jumped to the forefront by participating in a...

Continue Reading
U.S. GoldMining Eyes West Susitna Road Progress

Updated Category News Views 2

It's rare that infrastructure projects generate excitement, but U.S. GoldMining's nod to the West Susitna Access Project has the potential to shake things up in Alaska. On August 27, 2026, AIDEA greenlit a bold $25 million investment for geotechnical and engineering work, promising to bridge the Whistler Project with Southcentral Alaska's transport grid. Folks, we're...

Continue Reading
SCO at 25: China's Strategic Push for Regional Growth

Updated Category News Views 7

There's a new beat coming out of Central Asia, and it's resonating all the way from China's boardrooms to the barren landscapes of the Gobi Desert. With the Shanghai Cooperation Organization (SCO) celebrating its 25th anniversary, we're witnessing a pivot from a security-centric setup to a full-blown economic collaboration machine. The Landscape of SCO's Evolution Look,...

Continue Reading
Demand for Home Care Workers Soars: 850k by 2035

Updated Category News Views 3

A Looming Need for Home-based Care Take a long, deep breath and visualize this: by 2035, America's gonna need roughly 850,000 more home care workers. That's a head-spinning figure, and if you haven't been keeping up with the projections, let me fill you in on something the Bureau of Labor Statistics threw our way. They're saying home health and personal care aides will...

Continue Reading
Adecoagro Expands with Caarapó Mill Acquisition

Updated Category News Views 1

Crushing the Competition: Adecoagro's New Acquisition When there's dirt under your fingernails and deals in the air, taking a strategic swing like Adecoagro just did can be a game-changer. Shelling out R$705 million (roughly US$136 million) in cash isn't what you'd call pocket change, but they're not new to ballsy moves. They've snapped up the Caarapó Mill, previously...

Continue Reading
Chiraag Shah Joins Crowell & Moring in Major Move

Updated Category News Views 18

Shah's Strategic Move to Crowell & Moring The legal landscapes sometimes unfold like a strategic chessboard. Chiraag Shah just made a bold move by joining Crowell & Moring's International Dispute Resolution Practice in London. This isn't just a feather in the cap—it's a significant muscle flex in a competitive field where arbitration prowess can make or break...

Continue Reading
Telit Cinterion Secures U.S. Manufacturing with PA Facility

Updated Category News Views 0

Telit Cinterion Takes a Bold Step in U.S. Manufacturing Here's a move you don't see every day: Telit Cinterion, one of the leading players in the IoT scene, is planting its flag firmly in the good ol' U.S. of A. They're ramping up to start churning out 4G and 5G IoT modules right on American soil by October 2026. This isn't just a small-scale ambition, folks. We're...

Continue Reading
Moab Launches Free Shuttle to Enhance Park Access

Updated Category News Views 3

Moab's Shuttle: A New Era for Park Access A breeze of change is sweeping through the dusty trails of Moab, Utah, and this isn't just any switch—it's about making the always-packed Arches National Park a bit less of a traffic nightmare. Imagine this: strolling up to a shuttle, no tickets, no cash needed, and you're off to see epic scenery like The Windows and Delicate...

Continue Reading
McLean Launches Program to Foster AI Capability

Updated Category News Views 1

Driving AI Adoption: A Shift Towards Human-Centric Learning McLean & Company has dropped an initiative that’s like laying fresh tracks for AI inclusion in businesses. Dubbed the Human-Centric AI Program, it’s a wake-up call to organizations struggling to shift AI from a novelty to a natural part of operations. This isn’t just about fiddling with AI tools; it’s...

Continue Reading

Top 5 Most Recently Viewed Articles

Helport AI Launches Innovative Insurance Edition to Enhance Service

Updated Category News Views 118

Helport AI's New Horizons: Revolutionizing the Insurance Sector Collaboration with Several Leading Insurance Agencies to Pilot Advanced AI Solutions Helport AI Limited (NASDAQ: HPAI), an innovator in artificial intelligence technology, is thrilled to unveil the latest iteration of its Insurance Edition. This AI-based solution is tailored for the insurance industry,...

Continue Reading
Sagimet Biosciences to Showcase Breakthrough Fibrosis Data

Updated Category News Views 204

Exciting Developments from Sagimet Biosciences at the Upcoming AASLD 2024 Sagimet Biosciences Inc. (Nasdaq: SGMT), a pioneering biopharmaceutical company dedicated to developing innovative therapies for metabolic and fibrotic disorders, is set to present significant findings at the American Association for the Study of Liver Disease (AASLD) - The Liver Meeting 2024. This...

Continue Reading
Rimini Street Celebrates Achievements in Service Excellence

Updated Category News Views 210

A Remarkable Celebration: Rimini Street's Service Awards Rimini Street, Inc. (Nasdaq: RMNI), a leading global provider in enterprise software support, has recently been recognized with several prestigious awards. These accolades highlight the company’s commitment to excellence in service and client satisfaction, underscoring their role as a trusted partner for numerous...

Continue Reading
Michael Burry’s Generosity: Donating to Charity Through Substack

Updated Category News Views 155

Michael Burry's New Philanthropic Endeavor Michael Burry, renowned as a bearish investor, has recently taken a heartwarming step by pledging a portion of his subscription earnings to charity. This announcement adds a new dimension to his well-known persona. Burry informed the public about this philanthropic effort through a social media post where he committed to donating...

Continue Reading
Exploring Accenture PLC: Insights on This Trending Stock

Updated Category News Views 194

Examining Accenture PLC's Stock Trends Accenture (NYSE: ACN) has been a hot topic for investors recently. To understand how its stock is performing, it's essential to explore the various factors affecting its market presence. Keeping an eye on recent trends can offer valuable insights into how the stock may behave in the near future. Current Stock Performance Metrics In...

Continue Reading